This site is intended for health professionals only

J&J blames job cuts charge for fall in profits


Johnson & Johnson’s third-quarter profits fell about 8% because of a charge for cutting jobs, primarily in its stent-making and pharmaceuticals businesses, the company has said.

The company earned $2.5bn compared with a profit of $2.7bn during the same period last year.

Article continues below this sponsored advert
Cogora InRead Image
Explore the latest advances in clinical care at events delivered by renowned experts from CofE

Revenue rose to $14.9bn from $13.2bn, helped by strong results in international markets.

In July, the firm said it would reduce its global workforce by up to 4%, or up to 4,820 jobs, partly in order to cut costs due to falling sales of heart stents, plus looming patent expirations.

Copyright © PA Business 2007

Johnson & Johnson

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine